Fingerprint
Dive into the research topics of 'Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies
Merry L. Tetef, Timothy W. Synold, Warren Chow, Lucille Leong, Kim Margolin, Robert Morgan, James Raschko, Stephen Shibata, George Somlo, Yun Yen, James H. Doroshow, Susan Groshen, Kay Johnson, Heinz Josef Lenz, David Gandara
Research output: Contribution to journal › Article › peer-review
26
Citations
(Scopus)